| Grant number: | 10/20834-5 |
| Support Opportunities: | Regular Research Grants |
| Start date: | June 01, 2011 |
| End date: | November 30, 2013 |
| Field of knowledge: | Health Sciences - Medicine - Maternal and Child Health |
| Principal Investigator: | Beatriz Tavares Costa Carvalho |
| Grantee: | Beatriz Tavares Costa Carvalho |
| Host Institution: | Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil |
| Associated researchers: | Maria Isabel de Moraes Pinto |
Abstract
Hypogammaglobulinemia is the reduction of serum immunoglobulin levels due to primary or secondary causes. Common Variable Immunodeficiency (CVID) is a primary hypogammaglobulinemia clinically defined by the presence of recurrent infections after 2 years of age, a reduction of IgG levels and at least one other Ig isotype. The CVID patients also present a failure to generate a specific antibody response after vaccination or natural infection. In CVID, other known genetic or acquired causes of hypogammaglobulinemia have been excluded. Several studies have shown alterations in B lymphocytes in CVID adult patients, but there is insufficient data on these cells in children.Our hypothesis is that children and adults with CVID present separate distinct features, especially regarding B cells subsets. The objective of this project is to study the B lymphocyte subsets in children with hypogammaglobulinemia and to compare these with healthy controls matched by gender and age (10 children). The patients with CVID diagnosis (10 children and 10 adults) will be selected from the Division of Allergy, Clinical Immunology and Rheumatology -UNIFESP. All patients are being treated with regular intravenous immunoglobulin (IVIG). Clinical data will be collected by questionnaire based on the medical reports. For each subject, blood samples will be colleted immediately before IVIG infusion. We will study the number of TCD3, CD4, CD8, B cells (CD19) and Natural Killer cells (CD16 / CD56) by flow citometry. In order to study B cells subsets in depth we will use markers for:: 1- maturation: CD10, CD21, CD27, IgM, IgD and CD38; 2- activation: CD38, HLA-DR e CCR7; 3- regulatory B cells : CD24 and CD38. T cell function will be studied by interferon-gamma production after stimulation with tetanus antigen and the number of regulatory T cells will be quantified using CD25 and FOXP3 markers.The results of this study will allow a better understanding of B lymphocytes in children with hypogammaglobulinemia. Considering the heterogeneity of CVID, we intend to show that lymphocytes in children with this disease have distinct functional and phenotypic characteristics when compared with those of adult patients with CVID. A greater insight into B cells in this group of patients will help us in their management. (AU)
| Articles published in Agência FAPESP Newsletter about the research grant: |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |